Clinical Trial Update: Dietary Supplement of Curcumin in Subjects With Active Relapsing Multiple Sclerosis Treated With Subcutaneous Interferon Beta 1a [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a curcumin dietary supplement in patients with active relapsing multiple sclerosis treated with subcutaneous interferon beta-1a; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Curcumin (curcumin)
• Interferon beta-1a (Interferon beta-1a)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Multiple Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2019-01-22